As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy ...

HSBC and Axis Capital are more bullish on its transformative impact and future growth prospects for Glenmark, while Nuvama ...

IGI has partnered with AbbVie to grant exclusive rights to globally develop, manufacture, and commercialise ISB 2001 across ...

Tremfya snagged Dupixent’s place as the pharma brand with the most TV impressions in June, according to data released by iSpot.tv on Friday morning. The Johnson & Johnson brand garnered a 4.3% share ...

Today's rally followed Glenmark's Thursday announcement that its innovation arm, Ichnos Glenmark Innovation (IGI), has ...

The author includes U.S. and Canadian names, organized by country. Each company comes with a business summary, plus a bull ...

Glenmark Share Price: Glenmark Pharmaceuticals' arm Ichnos Glenmark Innovation has signed the deal for its lead investigational asset 'ISB 2001'.

The pharma began its outreach to the HS community well before securing Bimzelx’s approval in the indication. In the spring of ...

Trump's moves have raised fears that economic growth would slow to a trickle, if not make the U.S. and other nations more ...

Glenmark Pharmaceuticals shares rallied 10% on Friday to reach a record high after its biotech subsidiary signed a ...

Abbott Laboratories is a dividend growth machine that's known for consistency. AbbVie's dividend has more than quadrupled ...

Glenmark shares spike to 52-week high after $1.93 billion oncology deal with AbbVie — what should investors watch next? Glenmark stock surged over 10 per cent, hitting a fresh 52‑week high at Rs 1,905 ...